Allelic Variants
|
There are no related allelic variants
|
|
Number of involved diseases in the family |
64 |
Number of BLK related diseases |
1 |
All kinase in this family
BLK
Allelic Variants |
Disease Description |
Involved kinases (This family) |
Inhibitor of Involved Kinases |
Search Disease |
n/a | Measles | AKT1, AKT2, CDK2, CDK4, CDK6, FYN, GSK3B, JAK3, MAP3K7, PRKCQ | 80 | Link | n/a | Epstein-Barr virus infection | AKT1, AKT2, CDC2, CDK2, FGR, GSK3B, JAK3, MAP3K7, MAPK10 | 57 | Link | | Lung cancer | AKT1, AKT2, CDK2, CDK4, CDK6, PTK2 | 60 | Link | n/a | Influenza A | AKT1, AKT2, GSK3B, MAP2K1, MAPK10, PRKCA | 27 | Link | | Leukemia | ABL1, AKT1, AKT2, CDK4, CDK6, MAP2K1 | 53 | Link | | Melanoma | AKT1, AKT2, CDK4, CDK6, MAP2K1, MET | 46 | Link | | Prostate cancer | AKT1, AKT2, CDK2, GSK3B, MAP2K1, PDPK1 | 53 | Link | | Diabetes mellitus | AKT2, MAPK10, PRKCD, PRKCE, PRKCZ | 22 | Link | n/a | Herpes simplex infection | CDC2, CDK2, MAP3K7, MAPK10 | 42 | Link | n/a | Toxoplasmosis | AKT1, AKT2, MAP3K7, MAPK10 | 12 | Link | n/a | Hepatitis C | AKT1, AKT2, GSK3B, MAPK10 | 22 | Link | n/a | Tuberculosis | AKT1, AKT2, MAPK10, SRC | 59 | Link | n/a | Pathogenic Escherichia coli infection | ABL1, FYN, PRKCA | 12 | Link | n/a | Shigellosis | ABL1, MAPK10, SRC | 59 | Link | n/a | Immunodeficiencies | JAK3, LCK, ZAP70 | 21 | Link | n/a | Epithelial cell signaling in Helicobacter pylori infection | MAPK10, MET, SRC | 54 | Link | n/a | Chagas disease | AKT1, AKT2, MAPK10 | 11 | Link | n/a | Alcoholism | CAMKK2, MAP2K1, NTRK2 | 4 | Link | n/a | Salmonella infection | MAPK10, PKN1 | 5 | Link | | SCID | JAK3, LCK | 12 | Link | n/a | Prion diseases | FYN, MAP2K1 | 5 | Link | | Colon cancer | AURKA, SRC | 52 | Link | | Neuroblastoma | NTRK2, NTRK3 | 1 | Link | n/a | Amoebiasis | PRKCA, PTK2 | 6 | Link | n/a | Viral myocarditis | ABL1, FYN | 10 | Link | | Ovarian cancer | AKT1, AKT2 | 7 | Link | n/a | Maturity onset diabetes of the young | BLK | 1 | Link | | Colorectal cancer | AKT1 | 7 | Link | | Hypoinsulinemic hypoglycemia | AKT2 | 6 | Link | | Breast cancer | AKT1 | 7 | Link | n/a | PTEN hamartoma tumor syndrome | AKT1 | 7 | Link | n/a | Cervical cancer | CDK4 | 34 | Link | n/a | Proteus syndrome | AKT1 | 7 | Link | n/a | Familial partial lipodystrophy | AKT2 | 6 | Link | n/a | Schizophrenia | AKT1 | 7 | Link | | Mental retardation | DYRK1A | 1 | Link | n/a | Malignant melanoma | CDK4 | 34 | Link | n/a | Glycogen storage diseases | PHKG2 | 1 | Link | n/a | Obesity | NTRK2 | 1 | Link | n/a | Myasthenic syndrome | MUSK | 1 | Link | | Hepatocellular carcinoma | MET | 2 | Link | n/a | Congenital myasthenic syndrome | MUSK | 1 | Link | n/a | Cirrhosis due to liver phosphorylase kinase deficiency | PHKG2 | 1 | Link | | Glycogen storage disease | PHKG2 | 1 | Link | | Selective T-cell defect | ZAP70 | 11 | Link | n/a | Type I diabetes mellitus | PRKCQ | 15 | Link | n/a | Pituitary tumor | PRKCA | 2 | Link | n/a | Vibrio cholerae infection | PRKCA | 2 | Link | n/a | African trypanosomiasis | PRKCA | 2 | Link | n/a | Autism suseptibility | MET | 2 | Link | n/a | Malaria | MET | 2 | Link | n/a | Noonan syndrome and related disorders | MAP2K1 | 3 | Link | | Lymphoproliferative syndrome | ITK | 1 | Link | n/a | Basal cell carcinoma | GSK3B | 11 | Link | n/a | Glioma | CDK4 | 34 | Link | n/a | Legionellosis | CLK1 | 1 | Link | | Cardiofaciocutaneous syndrome | MAP2K1 | 3 | Link | n/a | Leishmaniasis | MAP3K7 | 1 | Link | | Renal cell carcinoma | MET | 2 | Link | n/a | Cholangiocarcinoma | MET | 2 | Link | | Gastric cancer | MET | 2 | Link | n/a | Epileptic encephalopathy | MAPK10 | 4 | Link | n/a | Early infantile epileptic encephalopathy | MAPK10 | 4 | Link | n/a | Pertussis | MAPK10 | 4 | Link |
|